US Broker Ratings

Opthea Limited (OPT) Stock Analysis: Navigating a Biotech’s Bold Phase 3 Path Amidst Market Skepticism

Opthea Limited (NASDAQ: OPT), an Australian biopharmaceutical company, commands attention within the healthcare sector for its pioneering work in the biotechnology industry. With a market capitalization..

PureTech Health plc (PRTC) Stock Analysis: Unpacking a 176% Potential Upside in the Biotech Sector

PureTech Health plc (NASDAQ: PRTC), a pioneering entity in the biotechnology space, is drawing significant attention thanks to its impressive potential upside of 176.14% as suggested..

Autolus Therapeutics (AUTL) Stock Analysis: A Biotech with 541% Potential Upside

Autolus Therapeutics plc (NASDAQ: AUTL), a promising player in the biotechnology sector, is captivating investor attention with its substantial growth potential. Despite a modest market cap..

Evolus, Inc. (EOLS) Stock Analysis: Is a 179% Potential Upside Worth the Risk?

Evolus, Inc. (NASDAQ: EOLS), a dynamic player in the healthcare sector, is capturing investor attention with an enticing potential upside of 179.01%. Specializing in the cash-pay..

Prothena Corporation plc (PRTA) Stock Analysis: A 33% Potential Upside in the Biotech Sector

Prothena Corporation plc (NASDAQ: PRTA) is an intriguing player in the biotechnology sector, focused on tackling the challenging landscape of neurodegenerative diseases and protein dysregulation disorders...

Abivax SA (ABVX) Investor Outlook: A Biotech Stock with a 29.60% Potential Upside

Abivax SA (ABVX), a French biotechnology company, has emerged as a notable contender in the healthcare sector, attracting investor attention with its promising drug pipeline and..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Biotech Trailblazer with a 26.53% Upside Potential

Maze Therapeutics, Inc. (NASDAQ: MAZE) emerges as a compelling player in the biotechnology sector, boasting a market capitalization of $1.44 billion. Operating out of South San..

ATAI Life Sciences (ATAI): Biotechnology Innovator with 118% Potential Upside

ATAI Life Sciences N.V. (NASDAQ: ATAI) stands at the forefront of biotechnology innovation, leveraging cutting-edge research to address pressing mental health challenges. With a compelling market..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Uncovering a 47% Potential Upside in the Biotech Sector

Cogent Biosciences, Inc. (NASDAQ: COGT) is drawing attention in the biotechnology sector with its promising potential upside of 47.12%. As a company dedicated to developing precision..

Oric Pharmaceuticals, Inc. (ORIC) Investor Outlook: A Promising 47% Upside Potential Amid Innovative Cancer Therapies

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a burgeoning player in the biotechnology sector, is capturing significant investor attention due to its innovative approach to combating cancer resistance..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating Volatility and Strategic Collaborations in the Biotech Sector

Fortrea Holdings Inc. (FTRE), a prominent player in the biotechnology industry, has been capturing the attention of investors with its strategic initiatives and volatile stock performance...

Personalis, Inc. (PSNL) Stock Analysis: Navigating a Complex Landscape with a Strong Buy Consensus

Personalis, Inc. (NASDAQ: PSNL), a prominent player in the healthcare sector, specializes in advanced cancer genomic tests and services. Despite facing significant challenges, including negative revenue..

Surmodics, Inc. (SRDX) Investor Outlook: Navigating Challenges and Opportunities in the Medical Device Sector

Surmodics, Inc. (NASDAQ: SRDX), a key player in the healthcare sector specializing in medical devices, finds itself at a critical juncture. With a market capitalization of..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Unpacking a 97% Potential Upside

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is capturing investor attention with its promising advancements in the biotechnology sector, specifically targeting central nervous system (CNS) disorders. With a..

Kamada Ltd. (KMDA) Stock Analysis: Exploring a 104% Potential Upside in the Healthcare Sector

Kamada Ltd. (NASDAQ: KMDA), an Israel-based healthcare company specializing in plasma-derived protein therapeutics, stands in a unique position within the drug manufacturing industry. With a market..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: A Biotech with a 72.88% Upside Potential

LENZ Therapeutics, Inc. (LENZ), a promising player in the biotechnology sector, is capturing investor attention with its focus on innovative therapies to enhance vision. Headquartered in..

Septerna, Inc. (SEPN) Stock Analysis: Biotechnology Innovator with 11.29% Potential Upside

Septerna, Inc. (NASDAQ: SEPN) is capturing the attention of investors in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $971.51 million,..

Tourmaline Bio, Inc. (TRML) Stock Analysis: Navigating the Biotech Landscape with a Steady Valuation

Tourmaline Bio, Inc. (NASDAQ: TRML), a dynamic player in the biotechnology sector, stands out with its niche focus on developing treatments for immune and inflammatory diseases...

Tilray Brands, Inc. (TLRY) Stock Analysis: Navigating a 20% Potential Upside in the Cannabis Market

For investors interested in the evolving cannabis market, Tilray Brands, Inc. (NASDAQ: TLRY) presents an intriguing opportunity with a potential upside of 20.50%. This Canadian-based company,..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 54% Potential Upside Amid Healthcare Innovation

AngioDynamics, Inc. (NASDAQ: ANGO), a notable player in the healthcare sector, is capturing investor attention with a compelling potential upside of 54.17%. As a specialist in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds